Agency Information Collection Activities: Proposed Collection; Comment Request, 70456-70459 [2011-28981]

Download as PDF 70456 Federal Register / Vol. 76, No. 219 / Monday, November 14, 2011 / Notices submissions may be made to the contact person on or before two days prior to the workgroup’s meeting date. Oral comments from the public will be scheduled at the conclusion of each workgroup meeting. Time allotted for each presentation will be limited to three minutes. If the number of speakers requesting to comment is greater than can be reasonably accommodated during the scheduled open public session, ONC will take written comments after the meeting until close of business on that day. Persons attending ONC’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. ONC welcomes the attendance of the public at its advisory committee meetings. Seating is limited at the location, and ONC will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Mary Jo Deering at least seven (7) days in advance of the meeting. ONC is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at http://healthit.hhs.gov for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (Pub. L. 92–463, 5 U.S.C., App. 2). Dated: November 7, 2011. Mary Jo Deering, Office of Policy and Planning, Office of the National Coordinator for Health Information Technology. [FR Doc. 2011–29356 Filed 11–10–11; 8:45 am] BILLING CODE 4150–45–P Decision To Evaluate a Petition To Designate a Class of Employees From Brookhaven National Laboratory, Upton, NY, To Be Included in the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS). ACTION: Notice. mstockstill on DSK4VPTVN1PROD with NOTICES AGENCY: HHS gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees from Brookhaven National Laboratory, Upton, New York, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation VerDate Mar<15>2010 19:40 Nov 10, 2011 Jkt 226001 John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. 2011–29312 Filed 11–10–11; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Decision To Evaluate a Petition To Designate a Class of Employees From Sandia National Laboratory, Albuquerque, NM, To Be Included in the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: HHS gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees from Sandia National Laboratory, Albuquerque, New Mexico, to be included in the Special Exposure Cohort Under the Energy Employees Occupational Illness Compensation Program Act of 2000. The initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as follows: Facility: Sandia National Laboratory. Location: Albuquerque, New Mexico. Job Titles and/or Job Duties: All personnel who worked in any area. Period of Employment: January 1, 1963 through May 21, 2011. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, SUMMARY: DEPARTMENT OF HEALTH AND HUMAN SERVICES SUMMARY: Program Act of 2000. The initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as follows: Facility: Brookhaven National Laboratory. Location: Upton, New York. Job Titles and/or Job Duties: All employees of the Department of Energy, its predecessor agencies, and its contractors and subcontractors. Period of Employment: January 1, 1980 through December 31, 1993. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone (877) 222–7570. Information requests can also be submitted by Email to DCAS@CDC.GOV. PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone (877) 222–7570. Information requests can also be submitted by email to DCAS@CDC.GOV. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. 2011–29322 Filed 11–10–11; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Agency Information Collection Activities: Proposed Collection; Comment Request Agency for Healthcare Research and Quality, HHS. ACTION: Notice. AGENCY: This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project: ‘‘Evaluation of ARRA Comparative Effectiveness Research Dissemination Contractor Efforts.’’ In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501–3521, AHRQ invites the public to comment on this proposed information collection. This proposed information collection was previously published in the Federal Register on July 27th, 2011 and allowed 60 days for public comment. No comments were received. The purpose of this notice is to allow an additional 30 days for public comment. DATES: Comments on this notice must be received by December 14, 2011. ADDRESSES: Written comments should be submitted to: AHRQ’s OMB Desk Officer by fax at (202) 395–6974 (attention: AHRQ’s desk officer) or by email at OIRA_submission@omb.eop.gov (attention: AHRQ’s desk officer). Copies of the proposed collection plans, data collection instruments, and specific details on the estimated burden can be obtained from the AHRQ Reports Clearance Officer. FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports Clearance Officer, (301) 427–1477, or by email at doris.lefkowitz@r,AHRQ.hhs.gov. SUMMARY: SUPPLEMENTARY INFORMATION: E:\FR\FM\14NON1.SGM 14NON1 Federal Register / Vol. 76, No. 219 / Monday, November 14, 2011 / Notices Proposed Project mstockstill on DSK4VPTVN1PROD with NOTICES Evaluation of ARRA Comparative Effectiveness Research Dissemination Contractor Efforts Today, both patients and their health care providers have many options when deciding on a treatment plan. Information available to patients and their health care providers offers great opportunities for informed decision making. However, the volume of information that needs to be reviewed and synthesized can be daunting. To complicate matters, studies may offer conflicting information or have a conflict of interest (e.g., research sponsored by pharmaceutical companies that make drugs). Sorting through conflicting information requires a background in research that most patients do not have, and physicians have limited time to conduct these reviews. Having a neutral third party review research, draw conclusions, and disseminate findings is necessary to ensure effective health care delivery and consumption of quality care. AHRQ recognizes the need to fill this gap and has taken a lead role in developing mechanisms for reviewing and disseminating Comparative Effectiveness Research (CER) and findings to clinicians, health care decision makers, purchasers/business decision makers, and consumers through its Effective Healthcare Program (EHCP). CER directly compares the benefits, potential risks, and costs of two or more health care interventions. These direct comparisons allow assessments of how well a health care treatment or intervention works under real-world conditions. AHRQ has paid careful attention not only to how studies are conducted but also to how results are communicated to its audiences. To augment AHRQ’s existing CER dissemination efforts performed by the Eisenberg Center and other initiatives, AHRQ is conducting four one-time projects to test other ways to disseminate CER results. These four related projects will test new approaches to CER dissemination and promote awareness of the EHCP. Collectively, dissemination efforts will reach AHRQ’s priority audiences of: Clinical decision makers, health care system decision makers, purchasers/ business decision makers, public policy decision makers, and consumers/ patients. Through these four projects AHRQ aims to: (1) Educate professional and consumer audiences about CER; (2) inform professional and consumer audiences about AHRQ’s EHCP; (3) and VerDate Mar<15>2010 19:40 Nov 10, 2011 Jkt 226001 inform a wide range of audiences about new EHCP research findings. This project will evaluate the effectiveness of these four new dissemination efforts. The evaluation has four main goals: 1. Assess the effectiveness of the four dissemination strategies in creating awareness of CER, specific CER topics, and the EHCP. 2. Assess the effectiveness of the four dissemination strategies in fostering knowledge and understanding of CER finding, specific CER topics, and the EHCP. 3. Assess the effectiveness of the four dissemination strategies in promoting utilization, including use of the EHCP materials by consumers and by clinicians in patient care and if usage by clinicians is increasing across time. 4. Assess the effectiveness of the four dissemination strategies in supporting the benefits of using CER, and specific CER topics, for both patients and health care providers. This study is being conducted by AHRQ through its contractor, IMPAQ International, LLC and its subcontractor, Battelle Memorial Institute, pursuant to AHRQ’s statutory authority to conduct and support research on healthcare and on systems for the delivery of such care, including activities with respect to the quality, effectiveness, efficiency, appropriateness and value of healthcare services and with respect to clinical practice, including primary care and practice-oriented research. 42 U.S.C. 299a(a)(1) and (4). Method of Collection To achieve project goals the following data collections will be implemented, each of which apply to all of the abovestated goals: 1. Clinician Survey—Conduct three cross-sectional mail surveys with clinicians to measure awareness, understanding, use of the EHCP materials, and benefits of CER. Collecting survey data at multiple time points is critical to assess trends in the outcomes of interest among clinicians and the impact of ongoing and increased dissemination contractor activities. Three data points for the survey will allow us to test if the proportion of clinicians aware of CER and the Effective Healthcare Program is changing over time and if the rate of change is changing. The Survey will be administered at the end of years 1, 3 and 4; the burden for the year 4 data collection is not included in the estimates in Exhibits 1 and 2 since it will be included in a second OMB clearance package to be submitted after year 3. PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 70457 2. Consumer/Patient Survey— Conduct two cross-sectional telephone surveys with consumers/patients to measure awareness, understanding, use of the EHCP materials, and benefits of CER. Collecting survey data at multiple time points is critical to assess trends in the outcomes of interest among consumers/patients and the impact of ongoing and increased dissemination contractor activities. Two data points for the survey will allow us to test if the proportion of consumers/patients aware of CER and the Effective Healthcare Program is changing over time. The Survey will be administered at the end of years 1 and 3. A short screener questionnaire will be used to identify eligible respondents. 3. Health System Decision Maker Survey—Conduct one cross-sectional telephone survey with health care system decision makers to measure awareness, understanding, use of the EHCP materials, and benefits of CER. The questionnaire and respondent materials for this data collection are not included in this submission since it occurs in year 4 of the project and have not yet been developed. These materials will be submitted in another OMB clearance package in year 3 of this project. This data collection is mentioned here in order to provide an overview of the entire 5 years of the project; it is not included in the burden estimates in Exhibits 1 and 2. 4. Clinician Focus Groups—Conduct six follow-up focus groups with clinicians after the first and third crosssectional surveys of this audience. The focus groups will be conducted with three clinician segments: (1) Those who report awareness of CER and have selfreported use of CER in their clinical practice; (2) those who report awareness of CER and have self-reported non-use of CER in their clinical practice; and (3) those who report no awareness of CER. One moderator guide will be used for each focus group. By asking the same questions to each clinician segment, who will have been targeted by all four dissemination contractors, differences among answers are more likely to be attributed to the segmentation criteria and eliminate bias through different questions. Two focus groups will be conducted for each of the three segments. The clinician focus groups will be conducted by telephone. The focus groups will be administered at the end of year 2 and during year 5; the burden for the year 5 data collection is not included in the estimates in Exhibits 1 and 2 since it will be included in a second OMB clearance package to be submitted after year 3. E:\FR\FM\14NON1.SGM 14NON1 70458 Federal Register / Vol. 76, No. 219 / Monday, November 14, 2011 / Notices 5. Consumer/Patients Focus Groups— Conduct twelve follow-up focus groups with consumers/patients after the first cross-sectional survey of this audience, at the end of year 2 of the project. The focus groups will be conducted with three consumer/patient segments: (1) Those who report awareness of CER and have self-reported use of CER in medical decision making; (2) those who report awareness of CER and have self-reported non-use of CER in medical decision making; and (3) those who report no awareness of CER. Four focus groups will be conducted for each of the three segments. A single screening questionnaire will be used to recruit participants. The consumer/patient focus groups will be conducted by telephone. 6. Health System Decision Maker Focus Groups—Conduct twelve followup focus groups with health care system decision makers, after the crosssectional survey of this audience. The focus groups will be conducted with three decision maker segments: (1) Those who reported awareness of CER and have self-reported use of CER in business decision making; (2) those who reported awareness of CER and have self-reported non-use of CER in business decision making; and (3) those who report no awareness of CER. Four focus groups will be conducted for each of the three segments. The focus groups will be conducted by telephone. The screener, moderator guides, and respondent materials for this data collection are not included in this submission since it occurs in year 5 of the project and have not yet been developed. These materials will be submitted in another OMB clearance package in year 3 of this project. This data collection is mentioned here in order to provide an overview of the entire 5 years of the project; it is not included in the burden estimates in Exhibits 1 and 2. 7. Semi-Structured Interviews— Conduct semi-structured interviews, in year 3 of the project, with 20 individuals in each of the following groups: health care system decision makers, purchasers, and policymakers for a total of 60 interviews. In-depth interviews will be used to determine how people receive and interpret CERrelated materials and verbal information, and adopt new behaviors based on information they receive. AHRQ will use the survey, focus group, and in-depth interview data to assess trends and the effectiveness of the four complementary and different dissemination methods to inform current and future dissemination of the EHCP. Specific attention will be given to changes in audience awareness, understanding, behavior change/use, and benefits of CER. Collecting data at multiple times will enable AHRQ to determine whether increased dissemination contractors’ activities over time is associated with any change in CER awareness, knowledge, use, or benefit. Finally, collecting data from five audiences (i.e., clinicians, consumers/patients, health system decision makers, purchasers, and policy makers) will enable AHRQ to assess the effectiveness of its CER-related dissemination efforts among its target populations. Estimated Annual Respondent Burden Exhibit 1 shows the estimated annualized burden hours for the respondent’s time to participate in this evaluation. The total burden hours are estimated to be 3,760. Clinician Surveys: The design for the clinician survey consists of three cross sectional waves (only 2 of which are included in the estimates here, as explained in section 1), each wave having 1,926 respondents for a total of 3,852 across the two waves included in this information collection request. The survey will take no longer than 20 minutes to complete. Consumer/Patient Surveys: The design for the consumer/patient survey consists of two cross-sectional waves, each wave having 1,000 respondents for a total of 2,000 across both waves. The screener will take no longer than 5 minutes to complete. The survey will take no longer than 20 minutes to complete. Clinician Focus Groups: Six follow-up focus groups with clinicians will be conducted by telephone twice; once after the first and again after the third cross-sectional surveys of this audience (only one of which is included in the estimates here, as explained in section 1). Focus group participants will have completed the survey and will have expressed interest in participating in a telephone focus group. For each of the two rounds of focus groups, twelve clinicians will be recruited for each of six focus groups. Focus groups will last one hour. Consumer/Patient Focus Groups: Twelve follow-up focus groups with consumer/patients will be conducted by telephone after the first cross-sectional survey of this audience. Focus group participants will have completed the survey and will have expressed interest in participating in a telephone focus group. Eight people will be in each focus group. The screener will take no longer than 5 minutes to complete. Focus group will last approximately 90 minutes. In-Depth Interviews With Other Key Audiences: In-depth interviews will be conducted with up to 20 representatives in each of three key audiences: (1) Health care system decision makers, (2) purchasers, and (3) policy makers. Respondents located in the metropolitan Washington, DC/Baltimore area will be interviewed in person, and respondents located outside the local area will be interviewed by telephone. Participant recruitment should take no longer than five minutes. The interviews will last one hour. The estimated annualized cost burden associated with the respondent’s time to participate in this evaluation is shown in Exhibit 2. The total cost burden is estimated to be $144,266. EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents mstockstill on DSK4VPTVN1PROD with NOTICES Data collection activity Clinician Survey ............................................................................................... Consumer/Patient Survey: Screener ................................................................................................... Survey ....................................................................................................... Clinician Focus Groups ................................................................................... Consumer/Patient Focus Groups: Screener ................................................................................................... Focus Group ............................................................................................. Semi-structured Interviews with Health System Decision Makers .................. Semi-structured Interviews with Purchasers ................................................... VerDate Mar<15>2010 19:40 Nov 10, 2011 Jkt 226001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Number of responses per respondent Hours per response Total burden hours 3,852 1 20/60 1,284 2,560 2,000 72 1 1 1 5/60 20/60 60/60 214 667 72 120 96 20 20 1 1 1 1 5/60 90/60 60/60 60/60 10 144 20 20 E:\FR\FM\14NON1.SGM 14NON1 70459 Federal Register / Vol. 76, No. 219 / Monday, November 14, 2011 / Notices EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Data collection activity Number of responses per respondent Hours per response Total burden hours Semi-structured Interviews with Policymakers ................................................ 20 1 60/60 20 Total ................................................................................................... 8,760 n/a n/a 2,451 EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN Number of respondents Data collection activity Total burden hours Average hourly wage rate * Total cost burden Clinician Survey ............................................................................................... Consumer/Patient Survey: Screener ................................................................................................... Survey ....................................................................................................... Clinician Focus Groups ................................................................................... Consumer/Patient Focus Groups: Screener ................................................................................................... Focus Groups ........................................................................................... Semi-structured Interviews with Health System Decision Makers .................. Semi-structured Interviews with Purchasers ................................................... Semi-structured Interviews with Policymakers ................................................ 3,852 1,284 $88.46 $113,583 2,560 2,000 72 214 667 72 20.90 20.90 88.46 4,473 13,940 6,369 120 96 20 20 20 10 144 20 20 20 20.90 20.90 43.74 46.59 43.74 209 3,010 875 932 875 Total ................................................................................................... 8,760 2,451 n/a 144,266 * Based upon the mean of the average wages, National Compensation Survey: Occupational wages in the United States May 2009, ‘‘U.S. Department of Labor, Bureau of Labor Statistics.’’ Hourly wage rates for clinicians were estimated using the mean wage for internists (occupation code 29–1063). Hourly wage rates for consumers/patients were estimated using the mean wage for all occupations (occupation code 00–0000) since participants in the consumer groups may have a wide range of jobs and occupations. Hourly wage rates for health system decision makers and policymakers were estimated using the mean wage for medical and health services managers (occupation code 11–9111). Hourly wage rates for purchasers were estimated using the mean wage for purchasing managers (occupation code 11–3061). These rates were obtained in January 2011 at the following Web site: http://www.bls.gov/oes/current/oes_nat.htm#b29-0000. Estimated Annual Costs to the Federal Government over the five years of the project. Exhibit 3 provides a breakdown of these costs. The total cost to the Government for this information collection is $2,719,272 EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST Cost component Total cost Annualized cost $420,055 1,452,290 141,637 291,706 413,584 $84,011 290,458 28,327 58,341 82,717 Total .................................................................................................................................................................. mstockstill on DSK4VPTVN1PROD with NOTICES Project Development ............................................................................................................................................... Data Collection Activities ......................................................................................................................................... Data Processing and Analysis, and Reports to AHRQ ........................................................................................... Project Management ................................................................................................................................................ Overhead ................................................................................................................................................................. 2,719,272 543,854 Request for Comments In accordance with the Paperwork Reduction Act, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ healthcare research and healthcare information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to VerDate Mar<15>2010 19:40 Nov 10, 2011 Jkt 226001 enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. PO 00000 Frm 00053 Fmt 4703 Sfmt 9990 Dated: October 31, 2011. Carolyn M. Clancy, Director. [FR Doc. 2011–28981 Filed 11–10–11; 8:45 am] BILLING CODE 4160–90–M E:\FR\FM\14NON1.SGM 14NON1

Agencies

[Federal Register Volume 76, Number 219 (Monday, November 14, 2011)]
[Notices]
[Pages 70456-70459]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-28981]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Agency Information Collection Activities: Proposed Collection; 
Comment Request

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the intention of the Agency for 
Healthcare Research and Quality (AHRQ) to request that the Office of 
Management and Budget (OMB) approve the proposed information collection 
project: ``Evaluation of ARRA Comparative Effectiveness Research 
Dissemination Contractor Efforts.'' In accordance with the Paperwork 
Reduction Act, 44 U.S.C. 3501-3521, AHRQ invites the public to comment 
on this proposed information collection.
    This proposed information collection was previously published in 
the Federal Register on July 27th, 2011 and allowed 60 days for public 
comment. No comments were received. The purpose of this notice is to 
allow an additional 30 days for public comment.

DATES: Comments on this notice must be received by December 14, 2011.

ADDRESSES: Written comments should be submitted to: AHRQ's OMB Desk 
Officer by fax at (202) 395-6974 (attention: AHRQ's desk officer) or by 
email at OIRA_submission@omb.eop.gov (attention: AHRQ's desk officer).
    Copies of the proposed collection plans, data collection 
instruments, and specific details on the estimated burden can be 
obtained from the AHRQ Reports Clearance Officer.

FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports 
Clearance Officer, (301) 427-1477, or by email at 
doris.lefkowitz@r,AHRQ.hhs.gov.

SUPPLEMENTARY INFORMATION:

[[Page 70457]]

Proposed Project

Evaluation of ARRA Comparative Effectiveness Research Dissemination 
Contractor Efforts

    Today, both patients and their health care providers have many 
options when deciding on a treatment plan. Information available to 
patients and their health care providers offers great opportunities for 
informed decision making. However, the volume of information that needs 
to be reviewed and synthesized can be daunting. To complicate matters, 
studies may offer conflicting information or have a conflict of 
interest (e.g., research sponsored by pharmaceutical companies that 
make drugs). Sorting through conflicting information requires a 
background in research that most patients do not have, and physicians 
have limited time to conduct these reviews. Having a neutral third 
party review research, draw conclusions, and disseminate findings is 
necessary to ensure effective health care delivery and consumption of 
quality care.
    AHRQ recognizes the need to fill this gap and has taken a lead role 
in developing mechanisms for reviewing and disseminating Comparative 
Effectiveness Research (CER) and findings to clinicians, health care 
decision makers, purchasers/business decision makers, and consumers 
through its Effective Healthcare Program (EHCP). CER directly compares 
the benefits, potential risks, and costs of two or more health care 
interventions. These direct comparisons allow assessments of how well a 
health care treatment or intervention works under real-world 
conditions. AHRQ has paid careful attention not only to how studies are 
conducted but also to how results are communicated to its audiences.
    To augment AHRQ's existing CER dissemination efforts performed by 
the Eisenberg Center and other initiatives, AHRQ is conducting four 
one-time projects to test other ways to disseminate CER results. These 
four related projects will test new approaches to CER dissemination and 
promote awareness of the EHCP. Collectively, dissemination efforts will 
reach AHRQ's priority audiences of: Clinical decision makers, health 
care system decision makers, purchasers/business decision makers, 
public policy decision makers, and consumers/patients.
    Through these four projects AHRQ aims to: (1) Educate professional 
and consumer audiences about CER; (2) inform professional and consumer 
audiences about AHRQ's EHCP; (3) and inform a wide range of audiences 
about new EHCP research findings.
    This project will evaluate the effectiveness of these four new 
dissemination efforts. The evaluation has four main goals:
    1. Assess the effectiveness of the four dissemination strategies in 
creating awareness of CER, specific CER topics, and the EHCP.
    2. Assess the effectiveness of the four dissemination strategies in 
fostering knowledge and understanding of CER finding, specific CER 
topics, and the EHCP.
    3. Assess the effectiveness of the four dissemination strategies in 
promoting utilization, including use of the EHCP materials by consumers 
and by clinicians in patient care and if usage by clinicians is 
increasing across time.
    4. Assess the effectiveness of the four dissemination strategies in 
supporting the benefits of using CER, and specific CER topics, for both 
patients and health care providers.
    This study is being conducted by AHRQ through its contractor, IMPAQ 
International, LLC and its subcontractor, Battelle Memorial Institute, 
pursuant to AHRQ's statutory authority to conduct and support research 
on healthcare and on systems for the delivery of such care, including 
activities with respect to the quality, effectiveness, efficiency, 
appropriateness and value of healthcare services and with respect to 
clinical practice, including primary care and practice-oriented 
research. 42 U.S.C. 299a(a)(1) and (4).

Method of Collection

    To achieve project goals the following data collections will be 
implemented, each of which apply to all of the above-stated goals:
    1. Clinician Survey--Conduct three cross-sectional mail surveys 
with clinicians to measure awareness, understanding, use of the EHCP 
materials, and benefits of CER. Collecting survey data at multiple time 
points is critical to assess trends in the outcomes of interest among 
clinicians and the impact of ongoing and increased dissemination 
contractor activities. Three data points for the survey will allow us 
to test if the proportion of clinicians aware of CER and the Effective 
Healthcare Program is changing over time and if the rate of change is 
changing. The Survey will be administered at the end of years 1, 3 and 
4; the burden for the year 4 data collection is not included in the 
estimates in Exhibits 1 and 2 since it will be included in a second OMB 
clearance package to be submitted after year 3.
    2. Consumer/Patient Survey--Conduct two cross-sectional telephone 
surveys with consumers/patients to measure awareness, understanding, 
use of the EHCP materials, and benefits of CER. Collecting survey data 
at multiple time points is critical to assess trends in the outcomes of 
interest among consumers/patients and the impact of ongoing and 
increased dissemination contractor activities. Two data points for the 
survey will allow us to test if the proportion of consumers/patients 
aware of CER and the Effective Healthcare Program is changing over 
time. The Survey will be administered at the end of years 1 and 3. A 
short screener questionnaire will be used to identify eligible 
respondents.
    3. Health System Decision Maker Survey--Conduct one cross-sectional 
telephone survey with health care system decision makers to measure 
awareness, understanding, use of the EHCP materials, and benefits of 
CER. The questionnaire and respondent materials for this data 
collection are not included in this submission since it occurs in year 
4 of the project and have not yet been developed. These materials will 
be submitted in another OMB clearance package in year 3 of this 
project. This data collection is mentioned here in order to provide an 
overview of the entire 5 years of the project; it is not included in 
the burden estimates in Exhibits 1 and 2.
    4. Clinician Focus Groups--Conduct six follow-up focus groups with 
clinicians after the first and third cross-sectional surveys of this 
audience. The focus groups will be conducted with three clinician 
segments: (1) Those who report awareness of CER and have self-reported 
use of CER in their clinical practice; (2) those who report awareness 
of CER and have self-reported non-use of CER in their clinical 
practice; and (3) those who report no awareness of CER. One moderator 
guide will be used for each focus group. By asking the same questions 
to each clinician segment, who will have been targeted by all four 
dissemination contractors, differences among answers are more likely to 
be attributed to the segmentation criteria and eliminate bias through 
different questions. Two focus groups will be conducted for each of the 
three segments. The clinician focus groups will be conducted by 
telephone. The focus groups will be administered at the end of year 2 
and during year 5; the burden for the year 5 data collection is not 
included in the estimates in Exhibits 1 and 2 since it will be included 
in a second OMB clearance package to be submitted after year 3.

[[Page 70458]]

    5. Consumer/Patients Focus Groups--Conduct twelve follow-up focus 
groups with consumers/patients after the first cross-sectional survey 
of this audience, at the end of year 2 of the project. The focus groups 
will be conducted with three consumer/patient segments: (1) Those who 
report awareness of CER and have self-reported use of CER in medical 
decision making; (2) those who report awareness of CER and have self-
reported non-use of CER in medical decision making; and (3) those who 
report no awareness of CER. Four focus groups will be conducted for 
each of the three segments. A single screening questionnaire will be 
used to recruit participants. The consumer/patient focus groups will be 
conducted by telephone.
    6. Health System Decision Maker Focus Groups--Conduct twelve 
follow-up focus groups with health care system decision makers, after 
the cross-sectional survey of this audience. The focus groups will be 
conducted with three decision maker segments: (1) Those who reported 
awareness of CER and have self-reported use of CER in business decision 
making; (2) those who reported awareness of CER and have self-reported 
non-use of CER in business decision making; and (3) those who report no 
awareness of CER. Four focus groups will be conducted for each of the 
three segments. The focus groups will be conducted by telephone. The 
screener, moderator guides, and respondent materials for this data 
collection are not included in this submission since it occurs in year 
5 of the project and have not yet been developed. These materials will 
be submitted in another OMB clearance package in year 3 of this 
project. This data collection is mentioned here in order to provide an 
overview of the entire 5 years of the project; it is not included in 
the burden estimates in Exhibits 1 and 2.
    7. Semi-Structured Interviews--Conduct semi-structured interviews, 
in year 3 of the project, with 20 individuals in each of the following 
groups: health care system decision makers, purchasers, and 
policymakers for a total of 60 interviews. In-depth interviews will be 
used to determine how people receive and interpret CER-related 
materials and verbal information, and adopt new behaviors based on 
information they receive.
    AHRQ will use the survey, focus group, and in-depth interview data 
to assess trends and the effectiveness of the four complementary and 
different dissemination methods to inform current and future 
dissemination of the EHCP. Specific attention will be given to changes 
in audience awareness, understanding, behavior change/use, and benefits 
of CER. Collecting data at multiple times will enable AHRQ to determine 
whether increased dissemination contractors' activities over time is 
associated with any change in CER awareness, knowledge, use, or 
benefit. Finally, collecting data from five audiences (i.e., 
clinicians, consumers/patients, health system decision makers, 
purchasers, and policy makers) will enable AHRQ to assess the 
effectiveness of its CER-related dissemination efforts among its target 
populations.

Estimated Annual Respondent Burden

    Exhibit 1 shows the estimated annualized burden hours for the 
respondent's time to participate in this evaluation. The total burden 
hours are estimated to be 3,760.
    Clinician Surveys: The design for the clinician survey consists of 
three cross sectional waves (only 2 of which are included in the 
estimates here, as explained in section 1), each wave having 1,926 
respondents for a total of 3,852 across the two waves included in this 
information collection request. The survey will take no longer than 20 
minutes to complete.
    Consumer/Patient Surveys: The design for the consumer/patient 
survey consists of two cross-sectional waves, each wave having 1,000 
respondents for a total of 2,000 across both waves. The screener will 
take no longer than 5 minutes to complete. The survey will take no 
longer than 20 minutes to complete.
    Clinician Focus Groups: Six follow-up focus groups with clinicians 
will be conducted by telephone twice; once after the first and again 
after the third cross-sectional surveys of this audience (only one of 
which is included in the estimates here, as explained in section 1). 
Focus group participants will have completed the survey and will have 
expressed interest in participating in a telephone focus group. For 
each of the two rounds of focus groups, twelve clinicians will be 
recruited for each of six focus groups. Focus groups will last one 
hour.
    Consumer/Patient Focus Groups: Twelve follow-up focus groups with 
consumer/patients will be conducted by telephone after the first cross-
sectional survey of this audience. Focus group participants will have 
completed the survey and will have expressed interest in participating 
in a telephone focus group. Eight people will be in each focus group. 
The screener will take no longer than 5 minutes to complete. Focus 
group will last approximately 90 minutes.
    In-Depth Interviews With Other Key Audiences: In-depth interviews 
will be conducted with up to 20 representatives in each of three key 
audiences: (1) Health care system decision makers, (2) purchasers, and 
(3) policy makers. Respondents located in the metropolitan Washington, 
DC/Baltimore area will be interviewed in person, and respondents 
located outside the local area will be interviewed by telephone. 
Participant recruitment should take no longer than five minutes. The 
interviews will last one hour.
    The estimated annualized cost burden associated with the 
respondent's time to participate in this evaluation is shown in Exhibit 
2. The total cost burden is estimated to be $144,266.

                                  Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of
            Data collection activity                 Number of     responses per     Hours per     Total burden
                                                    respondents     respondent       response          hours
----------------------------------------------------------------------------------------------------------------
Clinician Survey................................           3,852               1           20/60           1,284
Consumer/Patient Survey:
    Screener....................................           2,560               1            5/60             214
    Survey......................................           2,000               1           20/60             667
Clinician Focus Groups..........................              72               1           60/60              72
Consumer/Patient Focus Groups:
    Screener....................................             120               1            5/60              10
    Focus Group.................................              96               1           90/60             144
Semi-structured Interviews with Health System                 20               1           60/60              20
 Decision Makers................................
Semi-structured Interviews with Purchasers......              20               1           60/60              20

[[Page 70459]]

 
Semi-structured Interviews with Policymakers....              20               1           60/60              20
                                                 ---------------------------------------------------------------
        Total...................................           8,760             n/a             n/a           2,451
----------------------------------------------------------------------------------------------------------------


                                   Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
                                                     Number of     Total burden   Average hourly    Total cost
            Data collection activity                respondents        hours        wage rate *       burden
----------------------------------------------------------------------------------------------------------------
Clinician Survey................................           3,852           1,284          $88.46        $113,583
Consumer/Patient Survey:
    Screener....................................           2,560             214           20.90           4,473
    Survey......................................           2,000             667           20.90          13,940
Clinician Focus Groups..........................              72              72           88.46           6,369
Consumer/Patient Focus Groups:
    Screener....................................             120              10           20.90             209
    Focus Groups................................              96             144           20.90           3,010
Semi-structured Interviews with Health System                 20              20           43.74             875
 Decision Makers................................
Semi-structured Interviews with Purchasers......              20              20           46.59             932
Semi-structured Interviews with Policymakers....              20              20           43.74             875
                                                 ---------------------------------------------------------------
        Total...................................           8,760           2,451             n/a         144,266
----------------------------------------------------------------------------------------------------------------
* Based upon the mean of the average wages, National Compensation Survey: Occupational wages in the United
  States May 2009, ``U.S. Department of Labor, Bureau of Labor Statistics.'' Hourly wage rates for clinicians
  were estimated using the mean wage for internists (occupation code 29-1063). Hourly wage rates for consumers/
  patients were estimated using the mean wage for all occupations (occupation code 00-0000) since participants
  in the consumer groups may have a wide range of jobs and occupations. Hourly wage rates for health system
  decision makers and policymakers were estimated using the mean wage for medical and health services managers
  (occupation code 11-9111). Hourly wage rates for purchasers were estimated using the mean wage for purchasing
  managers (occupation code 11-3061). These rates were obtained in January 2011 at the following Web site: http://www.bls.gov/oes/current/oes_nat.htm#b29-0000.

Estimated Annual Costs to the Federal Government

    The total cost to the Government for this information collection is 
$2,719,272 over the five years of the project. Exhibit 3 provides a 
breakdown of these costs.

             Exhibit 3--Estimated Total and Annualized Cost
------------------------------------------------------------------------
                                                            Annualized
             Cost component                 Total cost         cost
------------------------------------------------------------------------
Project Development.....................        $420,055         $84,011
Data Collection Activities..............       1,452,290         290,458
Data Processing and Analysis, and                141,637          28,327
 Reports to AHRQ........................
Project Management......................         291,706          58,341
Overhead................................         413,584          82,717
                                         -------------------------------
    Total...............................       2,719,272         543,854
------------------------------------------------------------------------

Request for Comments

    In accordance with the Paperwork Reduction Act, comments on AHRQ's 
information collection are requested with regard to any of the 
following: (a) Whether the proposed collection of information is 
necessary for the proper performance of AHRQ healthcare research and 
healthcare information dissemination functions, including whether the 
information will have practical utility; (b) the accuracy of AHRQ's 
estimate of burden (including hours and costs) of the proposed 
collection(s) of information; (c) ways to enhance the quality, utility, 
and clarity of the information to be collected; and (d) ways to 
minimize the burden of the collection of information upon the 
respondents, including the use of automated collection techniques or 
other forms of information technology.
    Comments submitted in response to this notice will be summarized 
and included in the Agency's subsequent request for OMB approval of the 
proposed information collection. All comments will become a matter of 
public record.

    Dated: October 31, 2011.
Carolyn M. Clancy,
Director.
[FR Doc. 2011-28981 Filed 11-10-11; 8:45 am]
BILLING CODE 4160-90-M